Long-Term Safety Study of Tafenoquine

NCT03320174 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Tafenoquine
OTHER: Placebo

Sponsor

60 Degrees Pharmaceuticals LLC